120 Duplication in CHIT1 gene and the risk for Aspergillus lung disease in CF patients  by Livnat, G. et al.
Posters 6. Microbiology − Pathogenesis S79
120 Duplication in CHIT1 gene and the risk for Aspergillus lung
disease in CF patients
G. Livnat1, R. Bar-Yoseph1, A. Mory1, E. Dagan1, N. Elias1, R. Gershoni2,
L. Bentur2. 1Meyer Children’s Hospital, Rambam Health Care Campus, Haifa,
Israel; 2Meyer Children’s Hospital, Rambam Health Care Campus The Bruce
Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa,
Israel
Background: Aspergillus often persists in the respiratory tract of patients with Cys-
tic Fibrosis (CF) and may cause allergic broncho pulmonary aspergillosis (ABPA).
Chitinases are enzymes that digest the chitin polymer. Plants use chitinase as a
defense mechanism against fungi. Chitotriosidase (CHIT1) is the major chitinase in
human airways. Variation in the coding region with 24-bp duplication allele results
in reduced CHIT1 activity. Recently, CHIT1 duplication heterozygocity was found
in 6/6 patients with severe asthma and fungal sensitization (SAFS).
Our aim was to evaluate the link between CHIT1 duplication in CF patients and
the predisposition to Allergic bronchopulmonary mycosis (ABPM) or persistent
Aspergillus positive sputum (APS).
Patients and Methods: CHIT1 duplication was assessed in three CF groups.
Group 1: patients who had neither ABPA nor APS in the past (control group).
Group 2: patients with persistent APS (2/year), without ABPA.
Group 3: patients with current or past ABPM.
Results: Forty patients with CF were included in the analysis, CHIT1 duplication
heterozygocity was found in 3/6 (50%) of the patients in the ABPM group, 3/12
(25%) in the APS group, and 7/22 (31.8%) in the control group (P > 0.05). Eleven
patients were heterozygous for W1282X CF mutation, 90.9% were negative for
CHIT1 duplication. Five patients were homozygous for W1282X; none of them
had CHIT1 duplication or ABPA.
Conclusions: CHIT1 duplication is not found in all CF patients with ABPM in
contrast to patients with SAFS. These results suggest that CHIT1 duplication cannot
be the sole explanation for fungal positive sputum in CF patients.
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Objectives: Previously believed to be an innocent bystander in the cystic ﬁbrosis
(CF) microbiome, Candida has recently been considered to be a potential pathogen
in the CF airway. Candida colonisation has been shown to predict a greater FEV1
decline, and to also increase the rate of exacerbations in people with CF [1].
Methods: Here we characterised the Candida colonisation status of people with
CF attending three hospitals in Dublin. Sputum was spontaneously expectorated
from a deep cough and bronchoalveolar lavage (BAL) was obtained via ﬁbre-
optic bronchoscopy. Samples were liqueﬁed and serially diluted before plating
on CHROMagar and incubating at 37ºC for 48 hours. Based on the hydrolysis
of hexosaminidase in the media, Candida isolates were differentiated by colour.
C. dubliniensis is indistinguishable from C. albicans on this agar, however subcul-
ture and further incubation at 45ºC inhibits growth of C. dubliniensis. Of 80 sputum
samples from 44 adults with CF (30 male, 14 female; average age 25.8 years ±8.8),
63% of the adults (n = 28) were positive for Candida in at least one of their sputum
samples. 59% (n = 26), 13% (n = 6) and 4% (n = 2) had C. albicans, C. krusei
and C. dubliniensis respectively. BAL samples from 11 children with CF (4 male,
7 female; average age 3.4±2.1 years) were also cultured; none were positive for
Candida.
Conclusion: C. albicans is the most common Candida isolate in the sputum of
adults with CF. Candida was not present in pediatric BAL samples, indicating
that it may only be acquired at later stages, possibly after prolonged exposure to
broad-spectrum antibiotics.
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Objectives: Human rhinovirus is the most common viral respiratory infection
amongst patients with CF and is associated with signiﬁcant morbidity. The effect
of rhinovirus infection on the CF lung microbiome is unknown.
Methods: 5 adult CF patients with acute rhinovirus infection were identiﬁed. Se-
quential respiratory tract samples were collected during clinical stability, rhinovirus
infection and recovery. Standard bacterial culture and 16S rRNA pyrosequencing
were performed on paired sputum samples at each visit. A PCR panel for 9
respiratory viruses was also performed on sputum, nose- & throat-swabs. The
Shannon Index was calculated to quantify sputum bacterial diversity and analysed
using generalised estimating equation models.
Results: Median age of the patients was 31 years and all took regular azithromycin
and a nebulized antibiotic. 4/5 patients commenced additional antibiotics at the time
of rhinovirus infection. 16S rRNA pyrosequencing showed that rhinovirus infection
was associated with a substantial change in bacterial diversity in 4/5 patients. The
mean (SD) Shannon Index increased from 0.33 (0.46) at baseline to 0.74 (0.41)
at the virus-positive visit (p = 0.1). The mean Shannon Index fell to 0.19 (0.08) at
recovery (p< 0.001). In 3/5 cases rhinovirus was associated with a large increase in
the proportion of Streptococcus spp. and a corresponding decrease in the proportion
of the previously predominant bacterial pathogen.
Conclusion: Rhinovirus infection is frequently associated with changes in the bac-
terial diversity of CF sputum. The interaction between rhinovirus and Streptococcus
spp. in CF pulmonary exacerbations requires further exploration.
